Fongit is a startup incubator and accelerator located in Geneva, Switzerland, established in 1991. The organization focuses on supporting high-tech ventures, including startups, scale-ups, and small to medium-sized enterprises (SMEs) that are experiencing rapid growth. Fongit collaborates with local research institutions, universities, and higher education establishments to foster innovation, particularly in the fields of information and communications technology (ICT), engineering, and life sciences. The incubator is committed to advancing technological innovations that align with Sustainable Development Goals, thereby promoting a sustainable future through entrepreneurial efforts.
BrainScape Medical is a Swiss life sciences startup focused on developing an end-to-end solution for brain disorder management and care, addressing many limitations of current approaches.
MILOO
Debt Financing in 2025
Miloo is a Swiss electric mobility company that specializes in high-performance electric bikes designed for urban transportation. The company focuses on creating stylish and powerful e-bikes that enhance the commuting experience by offering greater range, comfort, and freedom. Assembled in Switzerland, Miloo's vehicles adhere to rigorous safety and performance standards, making them suitable for navigating city environments. The e-bikes are equipped with advanced engineering and digital tools, providing riders with a connected and enjoyable means of travel. Miloo aims to redefine urban mobility by offering a sustainable alternative to traditional transport options, allowing users to bypass traffic and crowded public transport while promoting clean and agile two-wheel mobility.
Cerret
Funding Round in 2025
Cerret is a Swiss jewelry brand that creates connected networks to empower individuals to feel protected, confident, and serene no matter where they are.
HekeTiss
Debt Financing in 2024
HekeTiss SA, a spin-off from the University Hospitals of Geneva and the University of Geneva, specializes in the manufacture of medical and dental instruments. The company has developed an innovative product called TrophiPatch, a cellular patch that mimics real skin and is engineered from stem cells derived from human adipose tissue. This advanced patch actively secretes factors that enhance the wound healing process, aiming to restore blood vessels in wounds. HekeTiss's TrophiPatch is designed to facilitate effective and cost-efficient treatment for chronic ulcers, significantly reducing the time required for healing.
Antion Biosciences
Debt Financing in 2024
Antion Biosciences SA is a biotechnology company based in Geneva, Switzerland, focused on cell and gene engineering. The company develops off-the-shelf therapies aimed at treating diseases that have significant unmet medical needs, particularly in the realm of autoimmune diseases. Antion utilizes proprietary technology to create multiplexed gene-modified cell therapies, enabling a modular and tunable approach to therapeutic cell engineering. This innovative method not only enhances clinical safety and efficacy but also aims to ensure broad accessibility of treatments, even in resource-poor communities. Recently, Antion has shifted its focus to repurpose its miCAR19 developments for autoimmune conditions, building on promising preclinical proof-of-concept data from its lead product, miCAR7. The company is positioned as one of the few in the field offering an allogeneic solution, with significant progress made towards achieving proof-of-concept in human trials.
HeroSupport
Seed Round in 2024
HeroSupport is a medical device manufacturing company that transforms imaging and/or treatment tables into personalized solutions. The company was founded in 2019 and is headquartered in Veyrier, Geneva.
Transmutex
Series A in 2024
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.
KYLYS
Debt Financing in 2023
KYLYS is an innovative Swiss company based in Geneva founded in March 2017. KYLYS provides people and patients with highly effective and safe products based on biomolecules.
Plair SA
Debt Financing in 2023
Plair SA specializes in the development and manufacturing of advanced systems for monitoring environmental conditions, particularly focusing on airborne particles. Founded in 2014 and based in Geneva, Switzerland, the company offers a range of innovative instruments, including the Particle Analyzer PA-300, which provides real-time detection, identification, and classification of fine particles in the air. This device can differentiate various entities such as pollen species, organic particles like fungal spores, and pollutants including polycyclic aromatic hydrocarbons. Additionally, Plair SA's Rapid-E and Rapid-C instruments utilize cutting-edge technologies like laser-induced fluorescence and light scattering for comprehensive analysis of aerosol particles. The company's solutions cater to applications in airborne allergen monitoring, air quality assessment, and bioaerosol analysis, enabling a deeper understanding of atmospheric aerosol concentrations. Plair SA is a spin-off from the University of Geneva, reflecting its strong academic foundation.
Endotelix
Debt Financing in 2023
Endotelix is a Swiss biotech start-up and a spin-off from the University of Geneva, focused on developing innovative solutions for Antiphospholipid Syndrome. The company specializes in creating fast, sensitive, and reliable diagnostic tests and treatment options aimed at detecting circulating antibodies associated with this condition. Endotelix primarily targets the healthcare needs of pregnant women and adolescent children, providing research tools and therapies that assist healthcare professionals in reducing pregnancy-related complications and enhancing overall healthcare outcomes.
EBAMed
Debt Financing in 2022
EBAMed SA is a Swiss startup based in Geneva, established in 2018, that focuses on developing innovative medical technology for treating heart arrhythmias. The company is working on an ultrasound-based device designed to monitor heart motion and facilitate non-invasive ablation therapy using proton beams. This technology aims to provide a safe and effective alternative for patients by allowing real-time synchronization of proton therapy with heart movement. By integrating both hardware and software components, EBAMed's device enhances treatment capabilities for existing proton therapy centers, enabling them to offer advanced, non-invasive treatment options for cardiac patients in an outpatient setting.
Terapet
Debt Financing in 2022
Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch.
Transmutex
Debt Financing in 2022
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.
GliaPharm
Debt Financing in 2022
GliaPharm SA is a Swiss biotechnology company focused on developing treatments for neurological and psychiatric disorders. Founded in 2016 and based in Geneva, the company utilizes its GliaX technology platform to identify drugs that target the activity of glial cells, which are essential support cells for neurons. This innovative approach aims to enhance brain metabolism in pathological conditions. GliaPharm employs high throughput screening technologies and conducts metabolic tests on both in vitro primary brain cell cultures and in vivo rodent models to evaluate compounds. The company addresses various neurological conditions, including Alzheimer's disease and amyotrophic lateral sclerosis (ALS), and collaborates with contract research organizations to advance its drug development and regulatory processes. With a vision to lead in glia-mediated therapies, GliaPharm seeks to provide new neuroprotective agents that support cognitive function in patients.
ABCDx
Convertible Note in 2021
ABCDx SA is a Swiss company founded in 2014 that specializes in the development, validation, and application of biomarker tests for brain injury treatment. The company focuses on creating biomarker panels designed to identify and diagnose patients at risk for severe long-term complications resulting from conditions such as traumatic brain injuries, strokes, and post-stroke infections. The founders are prominent researchers from the University of Geneva and the Vall d’Hebron Research Institute, bringing significant expertise in biomarker discovery and clinical application. They are complemented by a third founder with extensive experience in the diagnostic and pharmaceutical industries, enhancing the company’s capacity to innovate in brain health diagnostics.
HekeTiss
Grant in 2021
HekeTiss SA, a spin-off from the University Hospitals of Geneva and the University of Geneva, specializes in the manufacture of medical and dental instruments. The company has developed an innovative product called TrophiPatch, a cellular patch that mimics real skin and is engineered from stem cells derived from human adipose tissue. This advanced patch actively secretes factors that enhance the wound healing process, aiming to restore blood vessels in wounds. HekeTiss's TrophiPatch is designed to facilitate effective and cost-efficient treatment for chronic ulcers, significantly reducing the time required for healing.
HeroSupport
Grant in 2021
HeroSupport is a medical device manufacturing company that transforms imaging and/or treatment tables into personalized solutions. The company was founded in 2019 and is headquartered in Veyrier, Geneva.
Commochain
Pre Seed Round in 2019
CommoChain SA is a Swiss company founded in 2018 that specializes in developing a fintech platform for the commodity trading sector. The platform utilizes blockchain and smart contract technology to enhance the security of financial transactions, making them more streamlined and efficient. CommoChain focuses on simplifying the back-office operations for exporters and importers of commodities and raw materials. By providing a secure and accelerated method for executing physical transactions, the company aims to improve operational efficiency for businesses engaged in international trade.
MagicTomato
Venture Round in 2019
MagicTomato operates an online grocery marketplace that focuses on providing locally made and sourced products. Founded in September 2016 in the Geneva area, the company aims to encourage consumers to adopt healthier grocery shopping habits by offering a selection of over 800 non-industrial and GMO-free items. Their product range includes fresh fruits, vegetables, meats, fish, dairy, organic flours, and various beverages, all sourced from a network of 30 local artisans. MagicTomato emphasizes sustainability through a decentralized business model, aiming to eliminate food waste and packaging while ensuring ultimate freshness. They offer same-day delivery, making it convenient for consumers to access high-quality products from independent craftsmen in their region. The company is already at breakeven, reflecting its successful implementation of this innovative grocery approach.
Kejako
Seed Round in 2018
Kejako SA is a Swiss company specializing in the research and development of medical devices for the ophthalmic surgery sector, specifically targeting presbyopia. Founded in 2015 and headquartered in Plan-les-Ouates, Switzerland, Kejako aims to provide a non-invasive solution for patients experiencing a decline in visual accommodation due to age-related changes. The company employs a unique approach that combines simulation with minimally invasive treatments, utilizing a full eye 3D parametric model alongside multi-physics numerical modeling to assess the eye's optical and mechanical behavior. This innovation enables patients to better plan and control their customized procedures, ultimately enhancing their quality of life as they manage the effects of presbyopia.
Alohi
Seed Round in 2017
Alohi is a Swiss-based company that offers a cloud-based communication platform designed for entrepreneurs, small businesses, and individual consumers. Founded in 2015, Alohi provides services that include local phone numbers in various countries, along with features such as greeting messages, call forwarding, voicemail, fax, and announcements. The company focuses on two main platforms: one for self-service communications and another for legally binding electronic signatures. Its product lineup includes Sign.Plus, Fax.Plus, and Scan.Plus, which facilitate the electronic signing and verification of documents, as well as secure online fax services. This enables users to send and sign confidential documents safely, enhancing communication and agreement processes for both individuals and businesses.
MagicTomato
Seed Round in 2017
MagicTomato operates an online grocery marketplace that focuses on providing locally made and sourced products. Founded in September 2016 in the Geneva area, the company aims to encourage consumers to adopt healthier grocery shopping habits by offering a selection of over 800 non-industrial and GMO-free items. Their product range includes fresh fruits, vegetables, meats, fish, dairy, organic flours, and various beverages, all sourced from a network of 30 local artisans. MagicTomato emphasizes sustainability through a decentralized business model, aiming to eliminate food waste and packaging while ensuring ultimate freshness. They offer same-day delivery, making it convenient for consumers to access high-quality products from independent craftsmen in their region. The company is already at breakeven, reflecting its successful implementation of this innovative grocery approach.
ProtonVPN
Seed Round in 2017
ProtonVPN is Swiss-based VPN service, created by the same team of CERN scientists who created ProtonMail. ProtonVPN makes it possible to access the Internet without censorship and surveillance.
Quantreex
Pre Seed Round in 2017
Quantreex is a web-based trading platform founded in 2016 and based in Geneva, Switzerland. The platform allows users to create automated trading strategies quickly and efficiently, leveraging machine learning and artificial intelligence. It enables users to monitor and backtest financial strategies across various instruments and markets, ensuring that strategies are verified before going live. By simplifying the process of developing and executing trading strategies, Quantreex aims to help users capitalize on market opportunities effectively.
Gmelius
Pre Seed Round in 2017
Gmelius Ltd is a Swiss company founded in 2016 that specializes in developing a software extension designed to enhance workflow automation and team collaboration within Google Workspace. Its platform allows users to manage emails, track projects, and automate various tasks such as scheduling campaigns and setting follow-up reminders, all without the need for migrating data to external applications. Gmelius offers features like shared inboxes, Kanban boards, email templates, and integration with other tools like Slack and Trello, facilitating seamless communication and project management. The platform aims to de-silo company data and enhance productivity by enabling real-time collaboration directly from users' email inboxes. Gmelius has attracted over 10,000 paid customers, including notable companies like Netflix and JustWorks.
TwentyGreen
Seed Round in 2016
TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements designed for sustainable animal farming. Founded in 2015 and based in Root, Switzerland, the company has developed a triple active probiotic that addresses key challenges in intensive animal farming, such as improving digestion, enhancing responses to plant-based feeds, and promoting better feed conversion ratios. This innovative product, rooted in research on intestinal health from the École Polytechnique Fédérale de Lausanne (EPFL), aims to optimize gut microbiota, which is vital for food metabolism and immune defense. By offering significant benefits, such as reduced disease incidence and lower ecological impact, TwentyGreen seeks to capture a 10% share of the rapidly growing global animal feed probiotic market, valued at over $4 billion annually. To achieve this, the company engages in extensive research and development in collaboration with academic partners, ensuring compliance with regulatory standards for both human food and animal feed.
OrbiWise
Angel Round in 2016
OrbiWise is a Swiss company specializing in advanced technologies for the Internet of Things (IoT) industry, with a focus on developing a carrier-grade network server known as OrbiWAN, which is built on LoRa technology. This server enhances the performance of IoT services by providing real-time device messaging and targeted device group profiling, capable of supporting both single and multiple gateway access points across various environments, such as smart cities, rural areas, and industrial settings. OrbiWise's solutions aim to improve efficiency in agriculture and manufacturing, facilitate city parking, and enhance employee health and security. The company's team possesses a strong engineering background, with expertise in areas such as cloud and embedded software, communication systems, and RF/HW design. OrbiWise is committed to customer success and values honesty and innovation in its operations.
Prodibi
Seed Round in 2016
Prodibi is a professional image platform that enhances the online display of images to boost brand ROI, improve user engagement, and streamline the work of developers. Launched in 2011 and based in Geneva, Switzerland, the platform addresses common challenges in image quality, performance, color management, pixel density, responsiveness, and SEO, which can be costly and time-consuming to resolve. For example, tasks like cropping images can take significant time for graphic designers. Prodibi simplifies this process by allowing users to replace online images with a single click, ensuring an exceptional visual experience that aligns with brand prestige. The subscription-based service enables photographers, professional artists, and web publishers to showcase their work effectively on both web and mobile platforms without sacrificing speed or quality.
Expedismart
Seed Round in 2016
Expedismart is a courier service comparison platform based in Switzerland that facilitates the sending of mail and parcels both domestically and internationally. The company enables customers to compare various courier options, allowing them to choose the most suitable service based on quality, pricing, and preferred delivery times. By offering an online booking system, Expedismart aims to streamline the shipping process, ensuring that customers can efficiently manage their parcel deliveries while saving on costs.
Silver Wave Medical
Seed Round in 2016
Silver Wave is a Swiss company based in Geneva, founded by expert professionals from the pharma & medical device industries. Building on 25 years of experience, the team at Silver Wave has a leading reputation in the field of aesthetics, with experience in research and development as well as manufacturing and management that extends to many global healthcare companies. Silver Wave is built on the team’s experience and passion.
Multiwave Imaging
Seed Round in 2015
Multiwave Imaging is a leading company specializing in the design of metamaterial antennas for Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) systems. Established in March 2015 and headquartered in Geneva, Switzerland, with a research and development facility in France, Multiwave focuses on developing innovative medical imaging devices. The company aims to enhance imaging quality in MRI, ultimately aiding in the treatment of neurological conditions. In addition to its core imaging technologies, Multiwave employs advanced quantitative portfolio analysis and sensor technologies to support retailers in their purchasing strategies, thereby maximizing profits. Through these initiatives, Multiwave Imaging seeks to advance the field of medical imaging while addressing critical healthcare needs.
Planet Intus
Seed Round in 2015
Planet Intus SA specializes in the design and development of indoor geolocation software, providing infrastructure that supports both active and passive geolocation services. Founded in 2014 and headquartered in Carouge, Switzerland, the company offers a range of applications for end users, including indoor guidance, safety services, and comfort services. Its software aims to enhance user experiences in various sectors such as retail, leisure, healthcare, and security. Additionally, Planet Intus delivers analytics and insights to help professionals improve marketing strategies and operational efficiency. The team consists of skilled engineers and technicians with expertise in Geographic Information Systems, indoor positioning technologies, and mobile app development, combining French telecommunication know-how with Swiss quality standards to deliver innovative solutions.
InvestGlass
Seed Round in 2015
InvestGlass operates a web-based platform that provides a range of tools for investors and financial institutions. Founded in 2013 and based in Carouge, Switzerland, the platform includes features such as Strategy Tutor, which assists investors in managing their investment strategies, alongside access to global market data, news, forecasts, and corporate announcements. In addition, InvestGlass offers an Educational Portal filled with strategies, articles, tools, and videos aimed at enhancing market understanding. The platform also includes solutions for digital onboarding, customer relationship management, and portfolio management, all designed to streamline operations and improve service delivery. By leveraging artificial intelligence, InvestGlass enables its clients to focus more on providing investment advice while handling compliance and operational tasks efficiently.
Telexoo
Seed Round in 2014
Telexoo is a human-sized company based in Geneva, Switzerland. Their exchange specialists are at your disposal and directly reachable by phone or email. No call center, no ticket system. Just join us, as if you were calling a friend.
Aptissen
Seed Round in 2014
Aptissen SA, founded in 2013 as a spin-off of ANTEIS, is a Swiss company based in Plan-les-Ouates, specializing in the development and commercialization of hyaluronic acid polymer-based injectable medicinal products. The company focuses on aesthetic medicine, ophthalmology, and orthopedics, with notable innovations such as the Synolis VA range, which combines hyaluronic acid and sorbitol to provide rapid mobility recovery and effective pain relief for osteoarthritis patients. Aptissen also offers a food supplement called Cartylis aimed at joint health. Its products are distributed through a global network of distributors in over 50 countries, including Europe, South America, Canada, the Middle East, and Asia. The company operates subsidiaries in Italy, Poland, and France, and maintains certifications including CE, ISO13485, MDSAP, and GMP compliance, ensuring adherence to high-quality standards. Aptissen relies on subcontracting for production, sourcing materials from three suppliers located in Europe.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.